Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04517123 · ClinicalTrials.gov registry record · NA

Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT04517123: Completed NA study, sponsored by Johns Hopkins University.

NCT04517123 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04517123, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

The overall objective of this study is to determine whether a positional maneuver (e.g., prone positioning) decreases the need for escalation of respiratory-related care in patients with coronavirus (COVID-19) pneumonia.

Primary Outcome

Participants will be assessed for the occurrence of an escalation in respiratory related care (Yes or No). Escalation in respiratory related care is clinically defined as any of the following: 1. intubation 2. any increase in flow of supplemental oxygen 3. transition to high flow nasal cannula 4. increase in fraction of inspired oxygen 5. transfer from a lower to a higher level acuity of care (e.g. medical floor to intermediate care unit (IMC) or intensive care unit (ICU); IMC to ICU).

Interventions

  • OTHER Prone Positioning

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2020-09-01
Est. Completion 2021-12-31
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT04517123 record still lists

NCT04517123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Prone Positioning is the first listed.

NCT04517123 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04517123 about?

NCT04517123 is a clinical study titled "Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study". The overall objective of this study is to determine whether a positional maneuver (e.g., prone positioning) decreases the need for escalation of respiratory-related care in patients with coronavirus (COVID-19) pneumonia.

What is the current status of trial NCT04517123?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-09-01. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT04517123?

The interventions under investigation include: Prone Positioning (OTHER).

Who is sponsoring clinical trial NCT04517123?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04517123's enrollment target sits among peer trials

35 1564th of 2000 higher than 431 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04517123, the US trial registry maintained by the National Library of Medicine. NCT04517123 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.